Cross-links at abasic sites in duplex DNA

双链 DNA 脱碱基位点的交联

基本信息

  • 批准号:
    10524017
  • 负责人:
  • 金额:
    $ 39.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-15 至 2024-10-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Endogenous DNA damage can contribute to aging, sporadic cancers, and neurodegeneration. There are many sources of endogenous DNA damage, including oxidation, alkylation, nucleobase deamination, and hydrolysis of the glycosidic bond to generate abasic sites. DNA repair systems mitigate the effects of these endogenous damages, but some lesions inevitably evade repair with deleterious consequences. Importantly, not all DNA damage is created equal. Interstrand cross-links are exceptionally bioactive lesions because they block the DNA strand separation required for read-out and replication of genetic information in cells. Cells have no good answer to cross-links in their genome: Failure to repair cross-links may lead to cell death, tissue dysfunction, and aging, while error-prone repair may result in mutagenesis and cancer. The evolution and retention of elaborate cross-link repair systems across all walks of life suggest that the generation of endogenous interstrand cross-links is an unavoidable fact of life, but the identities of these cross-links and their biological consequences remain uncertain. The long-term objective of this application is to assess the occurrence and biological endpoints of endogenous DNA cross-links, which will contribute significantly to overall understanding of cancer etiology. Work during the previous grant period characterized a group of interstrand cross-links derived from an abasic (Ap) site that is the most common endogenous lesion found in cellular DNA. The work further developed LC-MS methods for the detection and characterization of these lesions in duplex DNA, and described a shuttle vector method for assessing the efficiency and fidelity with which the Ap-derived cross-links are repaired and replicated in human cells. The proposed work, will (1) conduct unbiased screens to comprehensively determine the sequence hotspots for Ap-derived cross-link formation, (2) detect the occurrence of Ap-derived cross-links in cellular DNA, and (3) determine the efficiency and fidelity with which Ap-derived cross-links are repaired in human cells and define the mechanisms of replication-dependent cross-link “unhooking” in vitro and in human cells. The proposed work explores the hypothesis that formation and replication-coupled repair of Ap-derived cross-links may be particularly important in cancer, neurodegeneration, and aging. The work is significant because the formation and repair of endogenous DNA cross-links may contribute to the causal processes involved in aging and early carcinogenesis. The work is innovative because it examines structurally novel cross-links and novel repair mechanisms, thus promising novel insights regarding the roles of endogenous DNA damage in human health and disease. In the long run, the results may enable understanding of how genetic differences in cross-link repair capacity contribute to human healthspan. Ultimately such insights could inspire approaches that improve health by genetic means or by pharmacological agents that inhibit the formation and/or enhance the repair of endogenous cross-links.
项目总结 内源性DNA损伤可能导致衰老、散发性癌症和神经退化。确实有 内源性DNA损伤的多种来源,包括氧化、烷基化、碱基脱氨和 糖苷键的水解以产生碱性中心。DNA修复系统减轻了这些影响 内源性损伤,但一些损伤不可避免地逃避修复,造成有害后果。重要的是 并不是所有的DNA损伤都是平等的。链间交联物是一种特殊的生物活性损伤,因为它们 阻断在细胞中读出和复制遗传信息所需的DNA链分离。单元格 对它们基因组中的交联链没有很好的答案:不能修复交联链可能会导致细胞死亡, 组织功能障碍和衰老,而容易出错的修复可能会导致突变和癌症。演变过程 各行各业对复杂的交叉链接修复系统的保留表明, 内源性链间交链是生命中不可避免的事实,但这些交链和 它们的生物学后果仍不确定。此应用程序的长期目标是评估 内源DNA交链的发生和生物终点,这将大大有助于 对癌症病因学有全面了解。前一批赠款期间的工作特点是一组 链间交叉链接源于基本(AP)部位,这是在 细胞DNA。这项工作进一步发展了LC-MS方法来检测和表征这些化合物 双链DNA中的损伤,并描述了一种评估穿梭载体方法的效率和保真度 AP衍生的交联链被修复并在人类细胞中复制。拟开展的工作,将(1) 进行无偏筛选,全面确定AP衍生交联链的序列热点 形成,(2)检测细胞DNA中AP衍生的交联链的出现,以及(3)确定 AP衍生的交叉连接在人类细胞中修复的效率和保真度,并定义了 在体外和在人类细胞中复制依赖的交联链“解钩”的机制。拟议中的工作 探索AP衍生的交叉链接的形成和复制耦合修复可能是 在癌症、神经退行性变和衰老中尤为重要。这项工作意义重大,因为 内源性DNA交联链的形成和修复可能有助于参与 衰老和早期致癌。这项工作具有创新性,因为它研究了结构新颖的交叉链接 和新的修复机制,从而对内源性DNA损伤的作用有了新的见解 在人类健康和疾病方面。从长远来看,这一结果可能有助于理解基因是如何 交链修复能力的差异有助于人类的健康。最终,这种洞察力可能会 启发通过遗传手段或通过抑制健康的药物来改善健康的方法 形成和/或增强内源性交联链的修复。

项目成果

期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
Formation and repair of unavoidable, endogenous interstrand cross-links in cellular DNA.
  • DOI:
    10.1016/j.dnarep.2020.103029
  • 发表时间:
    2021-03
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Housh K;Jha JS;Haldar T;Amin SBM;Islam T;Wallace A;Gomina A;Guo X;Nel C;Wyatt JW;Gates KS
  • 通讯作者:
    Gates KS
Mimicking Ribosomal Unfolding of RNA Pseudoknot in a Protein Channel.
Products Generated by Amine-Catalyzed Strand Cleavage at Apurinic/Apyrimidinic Sites in DNA: New Insights from a Biomimetic Nucleoside Model System.
  • DOI:
    10.1021/acs.chemrestox.1c00408
  • 发表时间:
    2022-02-21
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Jha, Jay S.;Nel, Christopher;Haldar, Tuhin;Peters, Daniel;Housh, Kurt;Gates, Kent S.
  • 通讯作者:
    Gates, Kent S.
Interstrand Cross-Link Formation Involving Reaction of a Mispaired Cytosine Residue with an Abasic Site in Duplex DNA.
  • DOI:
    10.1021/acs.chemrestox.1c00004
  • 发表时间:
    2021-04-19
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Varela JG;Pierce LE;Guo X;Price NE;Johnson KM;Yang Z;Wang Y;Gates KS
  • 通讯作者:
    Gates KS
Enabling novel paradigms: a biological questions-based approach to human chemical hazard and drug safety assessment.
实现新的范式:基于生物学问题的人类化学危害和药物安全评估方法。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kent S Gates其他文献

DNA-catalyzed hydrolysis of DNA phosphodiesters
DNA 催化的 DNA 磷酸二酯水解
  • DOI:
    10.1038/nchembio.224
  • 发表时间:
    2009-10-01
  • 期刊:
  • 影响因子:
    13.700
  • 作者:
    Mostafa I Fekry;Kent S Gates
  • 通讯作者:
    Kent S Gates
FaPy lesions and DNA mutations
法氏囊病变和 DNA 突变
  • DOI:
    10.1038/nchembio.1274
  • 发表时间:
    2013-06-17
  • 期刊:
  • 影响因子:
    13.700
  • 作者:
    Kent S Gates
  • 通讯作者:
    Kent S Gates

Kent S Gates的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kent S Gates', 18)}}的其他基金

Cross-links At Abasic Sites in Duplex DNA
双链 DNA 中无碱基位点的交联
  • 批准号:
    8664848
  • 财政年份:
    2012
  • 资助金额:
    $ 39.47万
  • 项目类别:
Cross-links At Abasic Sites in Duplex DNA
双链 DNA 中无碱基位点的交联
  • 批准号:
    8867233
  • 财政年份:
    2012
  • 资助金额:
    $ 39.47万
  • 项目类别:
Cross-links At Abasic Sites in Duplex DNA
双链 DNA 中无碱基位点的交联
  • 批准号:
    8372731
  • 财政年份:
    2012
  • 资助金额:
    $ 39.47万
  • 项目类别:
Cross-links at abasic sites in duplex DNA
双链 DNA 脱碱基位点的交联
  • 批准号:
    10295786
  • 财政年份:
    2012
  • 资助金额:
    $ 39.47万
  • 项目类别:
Cross-links at abasic sites in duplex DNA
双链 DNA 脱碱基位点的交联
  • 批准号:
    10054954
  • 财政年份:
    2012
  • 资助金额:
    $ 39.47万
  • 项目类别:
Cross-links At Abasic Sites in Duplex DNA
双链 DNA 中无碱基位点的交联
  • 批准号:
    8531243
  • 财政年份:
    2012
  • 资助金额:
    $ 39.47万
  • 项目类别:
Chemical and Biological Mechanisms of Leinamycin
莱纳霉素的化学和生物学机制
  • 批准号:
    7028123
  • 财政年份:
    2006
  • 资助金额:
    $ 39.47万
  • 项目类别:
Chemical and Biological Mechanisms of Leinamycin
莱纳霉素的化学和生物学机制
  • 批准号:
    7286021
  • 财政年份:
    2006
  • 资助金额:
    $ 39.47万
  • 项目类别:
Conference Grant: "DNA Alkylation: From Natural Products to Chemotherapy"
会议资助:“DNA烷基化:从天然产物到化疗”
  • 批准号:
    7159973
  • 财政年份:
    2006
  • 资助金额:
    $ 39.47万
  • 项目类别:
Chemical and Biological Mechanisms of Leinamycin
莱纳霉素的化学和生物学机制
  • 批准号:
    7470547
  • 财政年份:
    2006
  • 资助金额:
    $ 39.47万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 39.47万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 39.47万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 39.47万
  • 项目类别:
    Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 39.47万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 39.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 39.47万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 39.47万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 39.47万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 39.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 39.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了